Search Results for: ce
An Over-The-Counter Lifesaver: Increased Intranasal Naloxone Accessibility 2026
Learning Objectives After completing this application-based continuing education activity, pharmacists and pharmacy technicians will be able to · DISCUSS naloxone nasal spray’s shift to over-the-counter (OTC) availability · DESCRIBE how to use naloxone nasal spray safely and effectively · IDENTIFY the pharmacist’s role in OTC naloxone access Release Date: May 25, 2026 […]
Right Fit, Tight Seal: Building Better Cancer Care -RECORDED WEBINAR
About this Course This course is a recorded (home study version) of the Arthur E. Schwarting Symposium on April 17, 2026 . The theme was “Measure Twice, Cut Once: A Carpentry Approach to Pharmacy.” Learning Objectives Upon completion of this application based CE Activity, a pharmacist will be able to: Recognize ways that general […]
Resurgence of Lyme Disease: Key Insights for Pediatric Prophylaxis
Lyme Disease is being diagnosed earlier in the season and with increasing frequency. Diagnosed annual cases of Lyme Disease in the United States tripled from 2010 to 2023 (30,158 – 89,468).1 It is primarily concentrated in the Northeast and upper Midwest, with cases spanning from Maine through the Mid-Atlantic states and extending westward to Wisconsin.1 […]
Pediatric Bacterial Arthritis (Septic Arthritis): Takeaways for Pharmacy Practice (with additional data supporting oral therapy for some)
By Kenna Riley PharmD Candidate, Bacterial arthritis (e.g., septic arthritis) is caused by bacteria entering the joint from the bloodstream, causing infection and inflammation of the joint and synovial fluid.1 It requires prompt antibiotic treatment to prevent severe outcomes, such as irreversible joint damage. In 2023, the Pediatric Infectious Diseases Society (PIDS) and the […]
Empiric Treatment of Pediatric Pneumococcal Infections: Insights from a Recent Study
A recent article by Kaplan and colleagues was published in the Journal of Pediatric Infectious Diseases in November 2025 evaluating the pneumococcal serotypes and susceptibility of invasive pneumococcal disease in children.1 In this article, the authors evaluated pediatric pneumococcal disease in children admitted to 8 hospitals across the United States from 2018 – 2023. These […]
Henry A. Palmer CE Finale, LIVE December 19, 2025
Henry A. Palmer CE Finale, named for beloved professor and mentor, Dr. Henry A. Palmer, is a continuing education program offered at the end of each calendar year. Held during December, the program helps pharmacists fulfill their last-minute CE requirements. The program is an ala carte program offering a variety of presentations covering contemporary issues […]
Sugar, You’re Going Down: Recognition and Management of Hyperglycemic Crises
Learning Objectives After completing this continuing education activity, pharmacists will be able to REVIEW the definition and causes of hyperglycemic crises, including diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) DISCUSS the pathophysiology and presentation of DKA and HHS OUTLINE treatment recommendations for DKA and HHS APPLY strategies for optimizing DKA and HHS management After […]
Infant Hepatitis B Vaccine: A Key to U.S. Success
I have been a pharmacist that has been practicing for more than 20 years, and throughout this time, the US has alwways had an infant hepatitis B vaccine strategy in place. But this has not always been the case. Let’s look back in time to learn more. The first hepatitis B vaccine was introduced into […]
Pharmacist Reimbursement for Anticoagulation Services 2025 Revision
About this Course UConn has developed web-based continuing pharmacy education activities to enhance the practice of pharmacists and assist pharmacists in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve. There are a total of 17.25 hours of CPE credit available. Successful completion of these 17.25 hours (13 […]
Resilience vs. Resistance: Winning the Battle Against Vancomycin-Resistant Infections
Learning Objectives After completing this continuing education activity, pharmacists will be able to • EXPLAIN the common mechanisms of bacterial resistance and their impact on antibiotic efficacy • RECOGNIZE the importance of early and effective management of resistant bacterial infections. • IDENTIFY first- and second-line treatment options for VRE. After completing this continuing education activity, […]